Sources | Names Used |
---|---|
CTRPv2 | Compound 1541A |
PharmacoGx | Compound 1541A |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | MARK1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
mRNA | ASTN2 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
mRNA | POU2F3 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | ROMO1 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.003 |
mRNA | CNIH2 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
mRNA | GLYATL3 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | DLG3 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.003 |
mRNA | INTS7 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
mRNA | LRIT3 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
mRNA | SACM1L | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |